Status: Recruiting
A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)
The study (IP2015CS05) is a randomised, double-blind, placebo-controlled, 4-way cross-over trial studying the efficacy and safety of single dose administration of pudafensine in vulvodynia (provoked vestibulodynia) patients.
Participants needed: 24
Trial details
Phase: Phase 2Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Initiator PharmaUpdated: Feb 5, 2026Locations: 1
Eligibility criteria
Participant with vulvodynia (provoked vestibulodynia).
Infectious (e.g. recurrent candidiasis, herpes). [+11]